DDSDillard's, Inc.
Is the price fair?
Neither cheap nor expensive: modest expectations priced in, but at the top of its own P/E range.
Priced for ~1% a year FCF growth. Little growth is priced in even as revenue fell 2% a year over three years, potential value, or a value trap.
Expensive vs its own history: P/E 14.7 vs a 8.3 median over 34 quarters (+78% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What DDS's price assumes
Dillard's, Inc. trades at 14.7× earnings against 17.8× for the median Consumer Cyclical name, cheaper than its own group.
Trailing P/E · Consumer Cyclical median 17.8 · cheaper than the typical name in its group
- Price / sales
- 1.40
Price / sales · as of 2026-Q3
- Free cash flow yield
- 7.0%
Free cash flow yield · Consumer Cyclical median 6.0%
- Growth the price implies
- +1.2%
Growth the price implies · The price pays for +1.2% free cash flow growth a year for a decade; the business has delivered −12% a year over the last three.
Details›
- Price / bookas of 2026-Q3
- 4.34
- Consumer Cyclical median P/E321 names
- 17.8
- Free cash flow, trailing twelve months
- $635M
- Market capitalisation
- $9.08B
- 3-year revenue growth
- −1.7%
- 3-year free cash flow growth
- −12%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $278.70 |
| Its own P/E history, median | $360.80 |
| Its own P/E history, upper quartile | $473.06 |
| 52-week range | $523.57 – $699.91 |
| Today | $640.92 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.